217 related articles for article (PubMed ID: 25961442)
1. Endoscopically inserted nasobiliary catheters for high dose-rate brachytherapy as part of neoadjuvant therapy for perihilar cholangiocarcinoma.
Mukewar S; Gupta A; Baron TH; Gores G; Furutani K; Haddock MG; Hallemeier CL
Endoscopy; 2015 Oct; 47(10):878-83. PubMed ID: 25961442
[TBL] [Abstract][Full Text] [Related]
2. A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma.
Simmons DT; Baron TH; Petersen BT; Gostout CJ; Haddock MG; Gores GJ; Yeakel PD; Topazian MD; Levy MJ
Am J Gastroenterol; 2006 Aug; 101(8):1792-6. PubMed ID: 16780552
[TBL] [Abstract][Full Text] [Related]
3. [Percutaneous treatment of hilar cholangiocarcinoma completed by high-dose rate brachytherapy. Experience in the first 5 cases].
Righi D; Maass J; Zanon E; Tettoni S; Orecchia R; Lazzari R; Ragona R; Gandini G
Radiol Med; 1994; 88(1-2):79-85. PubMed ID: 7520594
[TBL] [Abstract][Full Text] [Related]
4. Palliation of unresectable cholangiocarcinoma: can we do more than merely drain?
Costamagna G; Boškoski I
Endoscopy; 2015 Oct; 47(10):871-2. PubMed ID: 26417968
[No Abstract] [Full Text] [Related]
5. Technique for the administration of high-dose-rate brachytherapy to the bile duct using a nasobiliary catheter.
Deufel CL; Furutani KM; Dahl RA; Grams MP; McLemore LB; Hallemeier CL; Neben-Wittich M; Martenson JA; Haddock MG
Brachytherapy; 2018; 17(4):718-725. PubMed ID: 29776892
[TBL] [Abstract][Full Text] [Related]
6. Video comment on Saurabh Mukewar et al.
Endoscopy; 2015 Oct; 47(10):v15. PubMed ID: 26417981
[No Abstract] [Full Text] [Related]
7. Unresectable perihilar cholangiocarcinoma: multimodal palliative treatment.
Mosconi C; Renzulli M; Giampalma E; Galuppi A; Balacchi C; Brandi G; Ercolani G; Bianchi G; Golfieri R
Anticancer Res; 2013 Jun; 33(6):2747-53. PubMed ID: 23749936
[TBL] [Abstract][Full Text] [Related]
8. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy.
Eschelman DJ; Shapiro MJ; Bonn J; Sullivan KL; Alden ME; Hovsepian DM; Gardiner GA
Radiology; 1996 Sep; 200(3):717-24. PubMed ID: 8756921
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation for unresectable perihilar cholangiocarcinoma.
Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Nyberg SL; Ishitani MB; Rosen CB
Semin Liver Dis; 2004 May; 24(2):201-7. PubMed ID: 15192792
[TBL] [Abstract][Full Text] [Related]
10. Placement of ¹²⁵I seed strands and stents for a type IV Klatskin tumor.
Zhang W; Yang ZQ; Shi HB; Liu S; Zhou WZ; Zhao LB
World J Gastroenterol; 2015 Jan; 21(1):373-6. PubMed ID: 25574114
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.
Darwish Murad S; Kim WR; Harnois DM; Douglas DD; Burton J; Kulik LM; Botha JF; Mezrich JD; Chapman WC; Schwartz JJ; Hong JC; Emond JC; Jeon H; Rosen CB; Gores GJ; Heimbach JK
Gastroenterology; 2012 Jul; 143(1):88-98.e3; quiz e14. PubMed ID: 22504095
[TBL] [Abstract][Full Text] [Related]
12. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of the Histologic Response of Perihilar Cholangiocarcinoma to Preoperative Neoadjuvant Chemoradiation in Liver Explants.
Lehrke HD; Heimbach JK; Wu TT; Jenkins SM; Gores GJ; Rosen CB; Mounajjed T
Am J Surg Pathol; 2016 Apr; 40(4):510-8. PubMed ID: 26752544
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of slimmer and open-cell-design stents for endoscopic bilateral stenting and endoscopic revision in patients with hilar cholangiocarcinoma (with video).
Kim JY; Kang DH; Kim HW; Choi CW; Kim ID; Hwang JH; Kim DU; Eum JS; Bae YM
Gastrointest Endosc; 2009 Dec; 70(6):1109-15. PubMed ID: 19647244
[TBL] [Abstract][Full Text] [Related]
15. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
[TBL] [Abstract][Full Text] [Related]
16. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma.
Welling TH; Feng M; Wan S; Hwang SY; Volk ML; Lawrence TS; Zalupski MM; Sonnenday CJ
Liver Transpl; 2014 Jan; 20(1):81-8. PubMed ID: 24115315
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status.
Kuriyama N; Usui M; Gyoten K; Hayasaki A; Fujii T; Iizawa Y; Kato H; Murata Y; Tanemura A; Kishiwada M; Sakurai H; Mizuno S; Isaji S
BMC Cancer; 2020 May; 20(1):405. PubMed ID: 32393197
[TBL] [Abstract][Full Text] [Related]
19. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
[TBL] [Abstract][Full Text] [Related]
20. A quality assurance device for measuring afterloader performance and transit dose for nasobiliary high-dose-rate brachytherapy.
Deufel CL; Mullins JP; Zakhary MJ
Brachytherapy; 2018; 17(4):726-731. PubMed ID: 29779953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
